ABVC BioPharma Provides Vitargus Update apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Clinical-stage biopharmaceutical company Invex Therapeutics (ASX: IXC) has been given the green light to start its EVOLVE phase three clinical trial in Australia on patients with idiopathic intracranial hypertension (IIH).
Skye Bioscience (SKYE) Granted Australian Ethics Committee Approval to Start First-in-Human Phase 1 Study of SBI-100 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.